These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3088027)

  • 1. Thyrotropin-releasing hormone cannot be detected in plasma from normal subjects.
    Iversen E
    J Clin Endocrinol Metab; 1986 Aug; 63(2):516-9. PubMed ID: 3088027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRH immunoreactivity in the thyroid gland.
    Iversen E; Weeke J; Laurberg P
    Scand J Clin Lab Invest; 1984 Dec; 44(8):703-9. PubMed ID: 6441998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High pressure liquid chromatography purification of human urinary samples for thyrotropin-releasing hormone radioimmunoassay.
    Leppäluoto J; Suhonen AS
    J Clin Endocrinol Metab; 1982 May; 54(5):914-8. PubMed ID: 6801077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma.
    Eskay RL; Oliver C; Warberg J; Porter JC
    Endocrinology; 1976 Feb; 98(2):269-77. PubMed ID: 813988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and excretion of exogenous thyrotropin-releasing hormone in humans.
    Bassiri RM; Utiger RD
    J Clin Invest; 1973 Jul; 52(7):1616-9. PubMed ID: 4198107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay of thyrotropin releasing hormone in plasma and urine.
    Saito S; Musa K; Yamamoto S; Oshima I; Funato T
    Endocrinol Jpn; 1975 Aug; 22(4):303-9. PubMed ID: 811457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
    Klootwijk W; de Herder WW; Kwekkeboom DJ; Lamberts SW; Krenning EP; Visser TJ; de Greef WJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2816-20. PubMed ID: 8768836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of thyrotropin-releasing hormone-like material in human peripheral blood by affinity chromatography and radioimmunoassay.
    Mallik TK; Wilber JF; Pegues J
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1194-8. PubMed ID: 6122693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma thyrotropin-releasing hormone concentrations in the rat. Effect of thyroid excess and deficiency and cold exposure.
    Emerson CH; Utiger RD
    J Clin Invest; 1975 Dec; 56(6):1564-70. PubMed ID: 811690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin-releasing hormone: further extraction studies and analysis by fast protein liquid chromatography and radioimmunoassay.
    Duntas L; Keck FS; Grouselle D; Rosenthal J; Wolf C; Pfeiffer EF
    J Endocrinol Invest; 1991 Mar; 14(3):173-9. PubMed ID: 1906494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunologic determination of the thyrotropin releasing hormone].
    Guignier F; Touzery C; Pelletier JL; Gailliard P
    C R Seances Soc Biol Fil; 1977; 171(6):1216-20. PubMed ID: 148950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunoassay of thyrotrophin releasing hormone in human serum and its clinical application.
    Mitsuma T; Hirooka Y; Nihei N
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):225-35. PubMed ID: 823752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower levels of thyrotropin-releasing hormone-degrading activity in human cord and in maternal sera than in the serum of euthyroid, nonpregnant adults.
    Neary JT; Nakamura C; Davies IJ; Soodak M; Maloof F
    J Clin Invest; 1978 Jul; 62(1):1-5. PubMed ID: 96140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a circulating N-extended form of the thyrotropin-releasing hormone-like peptide pGlu-Glu-Pro amide in human plasma.
    Ruiz-Alcaraz AJ; del Rio-Garcia J
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6002-7. PubMed ID: 14671203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotropin-releasing hormone immunoreactivity in the gastrointestinal tract of man.
    Dolva LO; Hanssen KF; Aadland E; Sand T
    J Clin Endocrinol Metab; 1983 Mar; 56(3):524-9. PubMed ID: 6401759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fast protein liquid chromatography (FPLC) method for study of thyrotropin-releasing hormone (TRH) and its metabolite histidyl-proline diketopiperazine (CHP) in human blood: degradation in liver and pancreatic diseases.
    Duntas L; Nelson DK; Grab BM; Rosenthal J; Maier V
    Neuropeptides; 1993 Dec; 25(6):357-61. PubMed ID: 8127415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluctuation of the plasma TRH level in normal subjects in a 4-hour observation period.
    Azukizawa M; Mitsuma T; Ota M; Miki T; Ichihara K; Kawashima M; Miyai K; Kumahara Y
    Endocrinol Jpn; 1980 Jun; 27(3):371-4. PubMed ID: 6777149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin releasing hormone (TRH) immunoreactivity and thyroid function in obesity.
    Duntas L; Hauner H; Rosenthal J; Pfeiffer EF
    Int J Obes; 1991 Jan; 15(1):83-7. PubMed ID: 1901299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.